TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer.
Maria Vittoria Dieci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.